Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 103 entries
View as:

The Exploration for Pharmacodynamics and Pharmacokinetics of YH4808 New Formulation in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02176668 Org: User:
Start: 06/30/14 End: 11/30/14 Due: 11/30/15

A Randomized, Open-label, Multiple-dose, Crossover Study to Investigate the Pharmacokinetic Drug Interaction Between Rosuvastatin and Telmisartan in Healthy Volunteer

Phase: N/A Priority: Normal
NCT ID: NCT01992601 Org: User:
Start: 11/30/12 End: 01/31/13 Due: 01/31/14

PK Study of YH22189 FDC Compared to Combination of Telmisartan/Amlodipine and Rosuvastatin

Phase: N/A Priority: Normal
NCT ID: NCT02608242 Org: User:
Start: 11/30/15 End: 06/30/16 Due: 06/30/17

HMG-CoA Reductase add-on in Chronic Kidney Disease Patients With Proteinuria

Phase: N/A Priority: Normal
NCT ID: NCT03550859 Org: User:
Start: 06/05/18 End: 12/31/21 Due: 12/31/22

Rosuvastatin/Amlodipine vs Atorvastatin/Amlodipine in Hypertension Patient With Dyslipidemia

Phase: N/A Priority: Normal
NCT ID: NCT03951207 Org: User:
Start: 05/30/19 End: 09/29/21 Due: 09/29/22

A Study to Evaluate the Effect of Sarpogrelate on Blood Hyperviscosity

Phase: N/A Priority: Normal
NCT ID: NCT03509922 Org: User:
Start: 10/11/18 End: 03/05/20 Due: 03/05/21

Study to Evaluate the Efficacy and Safety of TEL/AML/CTD in Elderly Patients with Essential Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT06282549 Org: User:
Start: 06/08/22 End: 03/31/27 Due: 03/31/28

Anagre Cap. in Patients With High-Risk Essential Thrombocythemia

Phase: N/A Priority: Normal
NCT ID: NCT03232177 Org: User:
Start: 06/05/17 End: 12/05/20 Due: 12/05/21

A Trial to Evaluate the Efficacy and Safety of YH12852 in Patients With Functional Dyspepsia

Phase: N/A Priority: Normal
NCT ID: NCT02567578 Org: User:
Start: 10/31/15 End: 03/16/17 Due: 03/16/18

Rosuvastatin/Ezetimibe vs Rosuvastatin in Korean Patients With Type 2 Diabetes Mellitus and Hypercholesterolemia

Phase: N/A Priority: Normal
NCT ID: NCT03446261 Org: User:
Start: 02/23/18 End: 03/05/19 Due: 03/05/20

A Clinical Trial of YH23537 in Patients With Knee Osteoarthritis

Phase: N/A Priority: Normal
NCT ID: NCT02759198 Org: User:
Start: 05/02/16 End: 09/26/17 Due: 09/26/18

High-Dose Statin Combined With Telmisartan vs Amlodipine on Glucose Metabolism in ASCVD Patients With IFG and Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT03474562 Org: User:
Start: 04/03/18 End: 06/07/19 Due: 06/07/20

Clinical Trial of YH25448(Lazertinib) as the First-line Treatment in Patients With EGFR Mutation Positive Locally Advanced or Metastatic NSCLC (LASER301)

Phase: N/A Priority: Normal
NCT ID: NCT04248829 Org: User:
Start: 02/13/20 End: 06/30/26 Due: 06/30/27

A Open-label, Randomized, Crossover Study to Assess PK of Pregabalin

Phase: N/A Priority: Normal
NCT ID: NCT02783183 Org: User:
Start: 06/30/16 End: 11/30/16 Due: 11/30/17

A FIH Study of YH35324 in Atopic Healthy Subjects or Subjects with Mild Allergic Diseases

Phase: N/A Priority: Normal
NCT ID: NCT05061524 Org: User:
Start: 09/26/21 End: 01/25/23 Due: 01/25/24

Clinical Trial of YHD1119 in Patients With Peripheral Neuropathic Pain

Phase: N/A Priority: Normal
NCT ID: NCT02985216 Org: User:
Start: 02/07/17 End: 05/02/18 Due: 05/02/19

Safety, Tolerability, Pharmacokinetics and Efficacy of YHD1044

Phase: N/A Priority: Normal
NCT ID: NCT01419470 Org: User:
Start: 02/28/11 End: 05/31/12 Due: 05/31/13

Study to Investigate the Safety, Tolerability and Efficacy of YH4808 in Patients With Reflux Esophagitis

Phase: N/A Priority: Normal
NCT ID: NCT01538849 Org: User:
Start: 12/31/12 End: 05/31/14 Due: 05/31/15

Clinical Trial to Evaluate the Efficacy and Safety of YHP1701

Phase: N/A Priority: Normal
NCT ID: NCT03103256 Org: User:
Start: 05/17/17 End: 04/30/18 Due: 04/30/19

A Study to Investigate Pharmacokinetic Drug Interaction and Safety of Telmisartan/Amlodipine and Rosuvastatin

Phase: N/A Priority: Normal
NCT ID: NCT02951962 Org: User:
Start: 08/31/16 End: 09/30/16 Due: 09/30/17

Comparative Pharmacokinetics of YH14659

Phase: N/A Priority: Normal
NCT ID: NCT01422109 Org: User:
Start: 07/31/11 End: 12/31/11 Due: 12/31/12

Rosuvastatin/Ezetimibe Versus Rosuvastatin in ASCVD Patients With Type 2 DM

Phase: N/A Priority: Normal
NCT ID: NCT03597412 Org: User:
Start: 10/17/18 End: 08/12/20 Due: 08/12/21

Safety, Tolerability and Efficacy of YH14618 in Patients With Degenerative Disc Disease

Phase: N/A Priority: Normal
NCT ID: NCT01526330 Org: User:
Start: 05/31/12 End: 07/31/14 Due: 07/31/15

Safety and Efficacy of YHD001 in Asthma

Phase: N/A Priority: Normal
NCT ID: NCT01424124 Org: User:
Start: 11/30/11 End: 01/31/14 Due: 01/31/15

Phase 1 Clinical Trial to Investigate the Effect on the Pharmacokinetics of YH14755 Compared to Co-administration of Rosuvastatin and Metformin SR in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02125227 Org: User:
Start: 04/30/14 End: 09/30/14 Due: 09/30/15